Evidence map›Paper›PMID 32210961›Full record

ArticleFrontiers in immunology2020

Dengue Virus Serotype 2 and Its Non-Structural Proteins 2A and 2B Activate NLRP3 Inflammasome.

Gaurav Shrivastava, Giovani Visoso-Carvajal, Julio Garcia-Cordero, Moisés Leon-Juarez, Bibiana Chavez-Munguia, Tomas Lopez, Porfirio Nava, Nicolás Villegas-Sepulveda, Leticia Cedillo-Barron

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Innate Immune and Inflammatory Responses to Dengue Virus Infection.Current topics in microbiology and immunology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Extracellular Vesicles inInternational journal of molecular sciences · 2024
    Review
  16. iScience · 2024
    Article
  17. Computational identification ofFrontiers in pharmacology · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Gaurav ShrivastavaDepartmento de Biomedicina Molecular Centro de Investigación y Estudios Avanzados-Instituto Politécnico Nacional, Mexico City, Mexico.
Giovani Visoso-CarvajalDepartmento de Biomedicina Molecular Centro de Investigación y Estudios Avanzados-Instituto Politécnico Nacional, Mexico City, Mexico.
Julio Garcia-CorderoDepartmento de Biomedicina Molecular Centro de Investigación y Estudios Avanzados-Instituto Politécnico Nacional, Mexico City, Mexico.
Moisés Leon-JuarezDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología, Mexico City, Mexico.
Bibiana Chavez-MunguiaDepartamento de Infectomica y Biologia Molecular, Centro de Investigación y Estudios Avanzados-Instituto Politécnico Nacional, Mexico City, Mexico.
Tomas LopezDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, UNAM Cuernavaca, Cuernavaca, Mexico.
Porfirio NavaDepartamento de Fisiologia, Biofisica y Neurociencias, Cinvestav Zacatenco, Mexico City, Mexico.
Nicolás Villegas-SepulvedaDepartmento de Biomedicina Molecular Centro de Investigación y Estudios Avanzados-Instituto Politécnico Nacional, Mexico City, Mexico.
Leticia Cedillo-BarronDepartmento de Biomedicina Molecular Centro de Investigación y Estudios Avanzados-Instituto Politécnico Nacional, Mexico City, Mexico.
Instituto Politécnico Nacional · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MXInstituto Nacional de Perinatología · MXUniversidad Del Valle De Cuernavaca · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue is the most prevalent and rapidly transmitted mosquito-borne viral disease of humans. One of the fundamental innate immune responses to viral infections includes the processing and release of pro-inflammatory cytokines such as interleukin (IL-1β and IL-18) through the activation of inflammasome. Dengue virus stimulates the Nod-like receptor (NLRP3-specific inflammasome), however, the specific mechanism(s) by which dengue virus activates the NLRP3 inflammasome is unknown. In this study, we investigated the activation of the NLRP3 inflammasome in endothelial cells (HMEC-1) following dengue virus infection. Our results showed that dengue infection as well as the NS2A and NS2B protein expression increase the NLRP3 inflammasome activation, and further apoptosis-associated speck-like protein containing caspase recruitment domain (ASC) oligomerization, and IL-1β secretion through caspase-1 activation. Specifically, we have demonstrated that NS2A and NS2B, two proteins of dengue virus that behave as putative viroporins, were sufficient to stimulate the NLRP3 inflammasome complex in lipopolysaccharide (LPS)-primed endothelial cells. In summary, our observations provide insight into the dengue-induced inflammatory response mechanism and highlight the importance of DENV-2 NS2A and NS2B proteins in activation of the NLRP3 inflammasome during dengue virus infection.

Indexed as

CARD Signaling Adaptor ProteinsCaspase 1Cell Line, TransformedDengueDengue VirusEndothelial CellsHumansImmunity, InnateInflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinViral Nonstructural ProteinsViroporin ProteinsVirulenceCARD Signaling Adaptor ProteinsCaspase 1InflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 Proteinnonstructural protein 2A, Dengue virusnonstructural protein 2B, Dengue virusPYCARD protein, humanViral Nonstructural ProteinsViroporin ProteinsCaspase-1dengueIL-1βinflammasomeNLRP3non-structural proteins NS2A and NS2Bviroporins

Identifiers

PMID32210961
PMCPMC7076137
OpenAlexW3011964495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.